PL436077A1 - Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNaz - Google Patents
Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNazInfo
- Publication number
- PL436077A1 PL436077A1 PL436077A PL43607720A PL436077A1 PL 436077 A1 PL436077 A1 PL 436077A1 PL 436077 A PL436077 A PL 436077A PL 43607720 A PL43607720 A PL 43607720A PL 436077 A1 PL436077 A1 PL 436077A1
- Authority
- PL
- Poland
- Prior art keywords
- rnase inhibitor
- ready
- recombinant human
- freeze
- human rnase
- Prior art date
Links
- 238000004108 freeze drying Methods 0.000 title abstract 4
- 239000003161 ribonuclease inhibitor Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 238000000338 in vitro Methods 0.000 abstract 3
- 238000011529 RT qPCR Methods 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000012669 liquid formulation Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 abstract 1
- 238000003757 reverse transcription PCR Methods 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Przedmiotem wynalazku są liofilizowana postać i gotowa do liofilizacji formulacja rekombinowanego ludzkiego inhibitora RNaz w wariancie dzikim SEQ ID NO 1 do zastosowań w biologii molekularnej i diagnostyce in vitro. Przedmiotem wynalazku są liofilizowany wariant rekombinowanego ludzkiego inhibitora RNaz oraz proces jego wytwarzania skutkujący sproszkowaną formą inhibitora RNaz zachowującą jego funkcjonalność i zwiększającą jego stabilność. Dodatkowo opracowano dla niego dedykowaną płynną formulację gotową do procesu liofilizacji (suszenia sublimacyjnego). Przedmiotem wynalazku jest możliwość wykorzystania obu postaci opisanych powyżej do diagnostyki in vitro oraz biologii molekularnej w procesach i zestawach do izolacji i oczyszczania materiału genetycznego RNA (kwas rybonukleinowy), systemach do syntez nici cDNA oraz technik RT-PCR, RT-qPCR, RT-LAMP, a także zestawów do transkrypcji i translacji in vitro i dedykowanych rozwiązań do amplifikacji RNA.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436077A PL436077A1 (pl) | 2020-11-25 | 2020-11-25 | Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNaz |
| EP21830807.0A EP4251643A1 (en) | 2020-11-25 | 2021-11-25 | Production and use of a freeze-dried or ready-for-lyophilization human rnase inhibitor |
| PCT/PL2021/000085 WO2022114981A1 (en) | 2020-11-25 | 2021-11-25 | Production and use of a freeze-dried or ready-for-lyophilization human rnase inhibitor |
| US18/035,143 US20230406894A1 (en) | 2020-11-25 | 2021-11-25 | Production and use of a freeze-dried or ready-for-lyophilization human rnase inhibitor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436077A PL436077A1 (pl) | 2020-11-25 | 2020-11-25 | Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNaz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL436077A1 true PL436077A1 (pl) | 2022-05-30 |
Family
ID=79021815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL436077A PL436077A1 (pl) | 2020-11-25 | 2020-11-25 | Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNaz |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230406894A1 (pl) |
| EP (1) | EP4251643A1 (pl) |
| PL (1) | PL436077A1 (pl) |
| WO (1) | WO2022114981A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025172388A1 (en) | 2024-02-15 | 2025-08-21 | Roche Diagnostics Gmbh | Compositions comprising an rnase inhibitor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0422217T3 (da) * | 1989-04-24 | 1998-03-02 | Promega Corp | Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion |
| US20040197795A1 (en) * | 2003-03-31 | 2004-10-07 | Fen Huang | Method of inactivating ribonucleases at high temperature |
-
2020
- 2020-11-25 PL PL436077A patent/PL436077A1/pl unknown
-
2021
- 2021-11-25 US US18/035,143 patent/US20230406894A1/en active Pending
- 2021-11-25 WO PCT/PL2021/000085 patent/WO2022114981A1/en not_active Ceased
- 2021-11-25 EP EP21830807.0A patent/EP4251643A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4251643A1 (en) | 2023-10-04 |
| WO2022114981A1 (en) | 2022-06-02 |
| US20230406894A1 (en) | 2023-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8168776B2 (en) | Method for making a 21 nucleotide double stranded RNA chemically linked at one end | |
| Taka et al. | MicroRNAs in Asthma and Respiratory Infections: Identifying Common Pathways. | |
| KR101984700B1 (ko) | 폴리뉴클레오티드 및 그의 용도 | |
| US20220380734A1 (en) | Systems and methods for lung cell expansion and differentiation | |
| WO2013118878A1 (ja) | 環状ｒｎａ及びタンパク質の製造方法 | |
| Sipert et al. | MicroRNA-146a and microRNA-155 show tissue-dependent expression in dental pulp, gingival and periodontal ligament fibroblasts in vitro | |
| CN114685588B (zh) | 一种含开环核苷结构的起始加帽寡核苷酸引物 | |
| BR0006915A (pt) | Sequências de nucleotìdios para o gene tal | |
| WO2023035372A1 (zh) | 一种有限自我复制mRNA分子系统、制备方法及应用 | |
| BRPI0507077A (pt) | processo para a preparação de l-aminoácidos usando cepas da famìlia enterobacteriaceae | |
| PL436077A1 (pl) | Liofilizowany i gotowy do liofilizacji rekombinowany ludzki inhibitor RNaz | |
| CN120641560A (zh) | Rna聚合酶变体及其应用 | |
| CN108546694B (zh) | 亚洲小车蝗蛋白酪氨酸磷酸酶ptpn4及其编码基因与应用 | |
| CN115678903B (zh) | 一种白背飞虱Ago1基因、合成dsRNA的方法及其应用 | |
| CN110724728A (zh) | 一种环状dna的制备方法 | |
| CN102382187A (zh) | Fbxl15蛋白片段及其编码基因和应用 | |
| US20230099592A1 (en) | Novel replicase cycling reaction (rcr) | |
| CN107904220B (zh) | 利用昆虫表达系统生产芦丁水解酶并制备槲皮素的方法 | |
| JP7807019B2 (ja) | 新規なレプリカーゼサイクリング反応（ｒｃｒ） | |
| CN107119137B (zh) | 一种快速检测HER‑2/neu基因表达的检测试剂盒 | |
| CN121160664B (zh) | Rna聚合酶变体 | |
| US12590329B2 (en) | Replicase cycling reaction (RCR) | |
| US20240093286A1 (en) | Novel Replicase Cycling Reaction (RCR) and the Related RdRP-Binding Site Designs Thereof | |
| AU2008202208B2 (en) | Method and medicament for inhibiting the expression of a defined gene | |
| CN101348522B (zh) | 抗铜二元信号传导系统调控因子突变体及其构建和应用 |